A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis

Clinical trial NCT01945086 · COMPLETED

Trial details

NCT number: NCT01945086
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2013-09-01
Primary completion: 2014-12-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.